EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Cognitive impairment and treatment strategy for atrial fibrillation in older adults: The SAGE‐AF study

Deepti S Athreya, Jane S Saczynski, Jerry H Gurwitz, Kevin M Monahan, Benita A Bamgbade iD, Tenes J Paul, Felix Sogade, Darleen M Lessard, David D McManus, Robert H Helm iD

Journal of the American Geriatrics Society · 2024

DOI: 10.1111/jgs.18949 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of the American Geriatrics Society, 2024. Verfasst von Deepti S Athreya und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Science, Northeastern University, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Cognitive Dysfunction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cognitive impairment is strongly associated with atrial fibrillation (AF). Rate and rhythm control are the two treatment strategies for AF and the effect of treatment strategy on risk of cognitive decline and frailty is not well established. We sought to determine how treatment strategy affects geriatric‐centered outcomes.

Methods

The Systematic Assessment of Geriatric Elements‐AF (SAGE‐AF) was a prospective, observational, cohort study. Older adults with AF were prospectively enrolled between 2016 and 2018 and followed longitudinally for 2 years. In a non‐randomized fashion, participants were grouped by rate or rhythm control treatment strategy based on clinical treatment at enrollment. Baseline characteristics were compared. Longitudinal binary mixed models were used to compare treatment strategy with respect to change in cognitive function and frailty status. Cognitive function and frailty status were assessed with the Montreal Cognitive Assessment Battery and Fried frailty phenotype tools.

Results

972 participants (mean age = 75, SD = 6.8; 49% female, 87% non‐Hispanic white) completed baseline examination and 2‐year follow‐up. 408 (42%) were treated with rate control and 564 (58%) with rhythm control. The patient characteristics of the two groups were different at baseline. Participants in the rate control group were older, more likely to have persistent AF, prior stroke, be treated with warfarin and have baseline cognitive impairment. After adjusting for baseline differences, participants treated with rate control were 1.5 times more likely to be cognitively impaired over 2 years (adjusted OR: 1.47, 95% CI:1.12, 1.98) and had a greater decline in cognitive function (adjusted estimate: −0.59 (0.23), p < 0.01) in comparison to rhythm control. Frailty did not vary between the treatment strategies.

Conclusions

Among those who had 2‐year follow‐up in non‐randomized observational cohort, the decision to rate control AF in older adults was associated with increased odds of decline in cognitive function but not frailty.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCognitive DysfunctionHumansFemaleMaleAgedProspective StudiesAged, 80 and overGeriatric AssessmentFrailtyLongitudinal StudiesAnticoagulantsAnti-Arrhythmia Agents

Stichwörter der Autor:innen

atrial fibrillationcognitive impairmentfrailtyolder adultsrate versus rhythm control

Substanzen

AnticoagulantsAnti-Arrhythmia Agents

Autor:innen und Institutionen

  • College of Science, Northeastern University, Boston, Massachusetts, USA.
  • Department of Pharmacy and Health System Sciences, Bouvé College of Health Sciences, Northeastern University, Boston, Massachusetts, USA.
  • Meyers Primary Care Institute and Division of Geriatric Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
  • Evans Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
  • Division of Cardiology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
  • Department of Medicine, Mercer University School of Medicine, Mercer, Georgia, USA.

ORCID-Profile: Benita A Bamgbade, Robert H Helm

Förderung

  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Athreya, D. S., Saczynski, J. S., Gurwitz, J. H., Monahan, K. M., Bamgbade, B. A., Paul, T. J., Sogade, F., Lessard, D. M., McManus, D. D., & Helm, R. H. (2024). Cognitive impairment and treatment strategy for atrial fibrillation in older adults: The SAGE‐AF study. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.18949

Vancouver

Athreya DS, Saczynski JS, Gurwitz JH, Monahan KM, Bamgbade BA, Paul TJ, et al. Cognitive impairment and treatment strategy for atrial fibrillation in older adults: The SAGE‐AF study. Journal of the American Geriatrics Society. 2024. doi:10.1111/jgs.18949

BibTeX
@article{Athreya2024,
  author = {Athreya, Deepti S and Saczynski, Jane S and Gurwitz, Jerry H and Monahan, Kevin M and Bamgbade, Benita A and Paul, Tenes J and Sogade, Felix and Lessard, Darleen M and McManus, David D and Helm, Robert H},
  title = {Cognitive impairment and treatment strategy for atrial fibrillation in older adults: The SAGE‐AF study},
  journal = {Journal of the American Geriatrics Society},
  year = {2024},
  doi = {10.1111/jgs.18949}
}
Kostenlos starten →